255 related articles for article (PubMed ID: 20121832)
1. Prediction of pre-eclampsia by an analysis of placenta-derived cellular mRNA in the blood of pregnant women at 15-20 weeks of gestation.
Sekizawa A; Purwosunu Y; Farina A; Shimizu H; Nakamura M; Wibowo N; Rizzo N; Okai T
BJOG; 2010 Apr; 117(5):557-64. PubMed ID: 20121832
[TBL] [Abstract][Full Text] [Related]
2. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic factors combined with clinical risk factors to predict preterm pre-eclampsia in nulliparous women: a predictive test accuracy study.
Myers JE; Kenny LC; McCowan LM; Chan EH; Dekker GA; Poston L; Simpson NA; North RA;
BJOG; 2013 Sep; 120(10):1215-23. PubMed ID: 23906160
[TBL] [Abstract][Full Text] [Related]
4. Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?
Myatt L; Clifton RG; Roberts JM; Spong CY; Wapner RJ; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Sciscione A; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
BJOG; 2013 Sep; 120(10):1183-91. PubMed ID: 23331974
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis.
Kleinrouweler CE; Wiegerinck MM; Ris-Stalpers C; Bossuyt PM; van der Post JA; von Dadelszen P; Mol BW; Pajkrt E;
BJOG; 2012 Jun; 119(7):778-87. PubMed ID: 22433027
[TBL] [Abstract][Full Text] [Related]
6. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery Doppler and markers of vasculogenesis during first trimester of pregnancy.
Parra-Cordero M; Rodrigo R; Barja P; Bosco C; Rencoret G; Sepúlveda-Martinez A; Quezada S
Ultrasound Obstet Gynecol; 2013 May; 41(5):538-44. PubMed ID: 22807133
[TBL] [Abstract][Full Text] [Related]
7. Angiogenic biomarkers for prediction of early preeclampsia onset in high-risk women.
Moore Simas TA; Crawford SL; Bathgate S; Yan J; Robidoux L; Moore M; Maynard SE
J Matern Fetal Neonatal Med; 2014 Jul; 27(10):1038-48. PubMed ID: 24066977
[TBL] [Abstract][Full Text] [Related]
8. Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers.
Wald NJ; Bestwick JP; George LM; Wu T; Morris JK
J Med Screen; 2012 Jun; 19(2):60-7. PubMed ID: 22547409
[TBL] [Abstract][Full Text] [Related]
9. Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.
Lim JH; Kim SY; Park SY; Yang JH; Kim MY; Ryu HM
Obstet Gynecol; 2008 Jun; 111(6):1403-9. PubMed ID: 18515525
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pre-eclampsia during early pregnancy in primiparas with soluble fms-like tyrosine kinase-1 and placental growth factor.
Rohra DK; Zeb A; Qureishi RN; Azam SI; Khan NB; Zuberi HS; Sikandar R
Natl Med J India; 2012; 25(2):68-73. PubMed ID: 22686711
[TBL] [Abstract][Full Text] [Related]
11. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
[TBL] [Abstract][Full Text] [Related]
12. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.
Levine RJ; Lam C; Qian C; Yu KF; Maynard SE; Sachs BP; Sibai BM; Epstein FH; Romero R; Thadhani R; Karumanchi SA;
N Engl J Med; 2006 Sep; 355(10):992-1005. PubMed ID: 16957146
[TBL] [Abstract][Full Text] [Related]
13. Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country.
Reyes LM; García RG; Ruiz SL; Broadhurst D; Aroca G; Davidge ST; López-Jaramillo P
Growth Factors; 2012 Jun; 30(3):158-66. PubMed ID: 22486210
[TBL] [Abstract][Full Text] [Related]
14. First-trimester prediction of preeclampsia in nulliparous women at low risk.
Myatt L; Clifton RG; Roberts JM; Spong CY; Hauth JC; Varner MW; Thorp JM; Mercer BM; Peaceman AM; Ramin SM; Carpenter MW; Iams JD; Sciscione A; Harper M; Tolosa JE; Saade G; Sorokin Y; Anderson GD;
Obstet Gynecol; 2012 Jun; 119(6):1234-42. PubMed ID: 22617589
[TBL] [Abstract][Full Text] [Related]
15. Failure of second-trimester measurement of soluble endoglin and other angiogenic factors to predict placental abruption.
Tikkanen M; Stenman UH; Nuutila M; Paavonen J; Hiilesmaa V; Ylikorkala O
Prenat Diagn; 2007 Dec; 27(12):1143-6. PubMed ID: 17960788
[TBL] [Abstract][Full Text] [Related]
16. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA in blood corpuscles combined with plasma protein factor for early prediction of pre-eclampsia.
Zhang YG; Yang HL; Long Y; Li WL
BJOG; 2016 Dec; 123(13):2113-2118. PubMed ID: 26846540
[TBL] [Abstract][Full Text] [Related]
18. Alterations of serum and placental endoglin in pre-eclampsia.
Fang M; He Y; Li H; Wu M; Shi X; Du H
J Int Med Res; 2010; 38(1):43-51. PubMed ID: 20233512
[TBL] [Abstract][Full Text] [Related]
19. Can maternal serum placental growth factor estimation in early second trimester predict the occurrence of early onset preeclampsia and/or early onset intrauterine growth restriction? A prospective cohort study.
Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
J Obstet Gynaecol Res; 2013 May; 39(5):881-90. PubMed ID: 23496304
[TBL] [Abstract][Full Text] [Related]
20. First-trimester serum levels of soluble endoglin and soluble fms-like tyrosine kinase-1 as first-trimester markers for late-onset preeclampsia.
Baumann MU; Bersinger NA; Mohaupt MG; Raio L; Gerber S; Surbek DV
Am J Obstet Gynecol; 2008 Sep; 199(3):266.e1-6. PubMed ID: 18771978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
